Corchorus trilocularis (L.) – A Comprehensive Pharmacological, Phytochemical and Therapeutic Review

Corchorus trilocularis (L.), commonly referred to as wild jute, trisegmented jute, or dwarf jute, represents an underutilized medicinal resource native to tropical and subtropical ecosystems worldwide. Belonging to the Malvaceae family (formerly Tiliaceae), this annual herbaceous plant has gained renewed scientific interest due to its rich phytochemical diversity and validated therapeutic potential. Traditional healers across Asia, Africa, and the Middle East have employed various plant parts for centuries to manage conditions ranging from gastric ulcers and diabetes to arthritis and infectious diseases. Recent advancements in analytical techniques such as GC-MS, HPLC, and NMR spectroscopy have unveiled a complex metabolomic profile dominated by bioactive secondary metabolites that underpin these ethnopharmacological claims. This review provides an exhaustive synthesis of current knowledge, bridging traditional wisdom with modern pharmacology to highlight C. trilocularis as a promising candidate for natural product drug discovery, particularly relevant for resource-limited healthcare systems in developing nations. ^[1][2][3] The genus Corchorus encompasses approximately 100-150 species, with C. trilocularis distinguished by its unique trilocular fruit morphology and medicinal prominence. Documented in classical Ayurvedic compendia such as Charaka Samhita (circa 1000 BCE) and Sushruta Samhita, the plant finds mention as "Trinapattr" for its therapeutic applications in tridosha imbalances, digestive disorders, and inflammatory conditions. In Siddha medicine prevalent in Tamil Nadu, seed decoctions serve as remedies for venereal diseases including syphilis, while Unani practitioners utilize leaf pastes for wound healing and skin disorders. African ethnomedicine employs the plant extensively; tribes in Nigeria and Senegal prepare leaf poultices for malaria fevers and tumor-like swellings, while Kenyan healers use seed infusions for griping abdominal pains and nausea.^[2][4][3][5] Nutritionally, the mucilaginous leaves provide a valuable vegetable source rich in vitamins A and C, iron, calcium, and dietary fiber, particularly important in rural diets where protein-energy malnutrition prevails. The plant's pharmacological renaissance began in the late 20th century with isolation of cardiac glycosides from seeds, followed by systematic phytochemical screening revealing triterpenoids, flavonoids, and phenolic antioxidants. Contemporary research validates traditional claims through standardized animal models, establishing dose-dependent efficacy across multiple therapeutic domains. This review systematically compiles botanical, chemical, pharmacological, and toxicological data, identifying research gaps and proposing clinical translation strategies essential for high-impact journal publication standards. ^[6][7][3]

Corchorus trilocularis (L.) bears vernacular names such as dwarf jute (English), ban pat (Hindi), and trisegmented jute across its native range. Documented in classical Ayurvedic texts like the Charaka Samhita and Sushruta Samhita, it has been employed for centuries to alleviate fever, dysentery, arthritic pains, and skin inflammations. In Siddha medicine of South India, seed decoctions treat venereal diseases like syphilis, while African traditional healers use leaf poultices for wound healing and malaria management. The plant's historical significance extends to nutritional use, with mucilaginous leaves consumed as a vegetable in rural diets, providing essential minerals and vitamins. Modern interest surged post-2000 with GC-MS profiling revealing cardiac glycosides and triterpenoids, linking folklore to science. This review synthesizes its botany, chemistry, pharmacology, and future potential, emphasizing evidence-based insights for clinical translation.^{[2] [4] [7] [6] [8][9][3]}

BOTANICAL DESCRIPTION

Corchorus trilocularis manifests as an annual, erect or semi-procumbent herb attaining heights of 30-150 cm, characterized by branched, pubescent stems covered in appressed hairs. Leaves are simple, alternate, ovate-lanceolate to elliptic (3-8 cm long, 1-3 cm wide), with acute apices, cuneate bases, and crenate-serrate margins; petioles measure 5-15 mm, accompanied by linear stipules. Inflorescences feature axillary, solitary or paired flowers on 3-10 mm pedicels, with five yellow sepals (4-5 mm) and petals, stamens numerous, and superior ovary forming trilocular capsules (8-12 mm diameter) upon maturation. Seeds are black, triangular, 2-3 mm, encased in loculicidal dehiscing fruits ripening October-November. Flowering aligns with monsoon cessation, aiding seed dispersal in arid zones. The plant exhibits C3 photosynthesis, drought tolerance via deep taproots, and allelopathic properties inhibiting nearby competitors. Microscopically, leaves show calcium oxalate crystals and anisocytic stomata, aiding taxonomic identification.^{[1][4] [10] [11] [3]}

The plant demonstrates remarkable ecological adaptability, thriving on sandy loam soils (pH 6.5-8.5) with low fertility and exhibiting C3 photosynthetic pathway efficiency under high light intensities (1200-1800 µmol m?² s?¹). Deep taproot systems facilitate drought tolerance, while allelopathic root exudates inhibit competing herbaceous growth, contributing to its weedy status in agroecosystems.^[4][7]

GEOGRAPHICAL DISTRIBUTION

Corchorus trilocularis proliferates in disturbed, anthropogenic habitats across Afro-Asian tropics, demonstrating ecological adaptability to semi-arid conditions.^{[4] [10]}

In India, particularly Lucknow (Uttar Pradesh), it invades fallow lands and roadsides, thriving on sandy loams (pH 6.5-8.0).^[4]

ETHNOMEDICINAL USES

Ethnopharmacological documentation reveals remarkable convergence across diverse cultures, consistently emphasizing gastrointestinal, anti-pyretic, and anti-inflammatory applications reflective of shared bioactive principles. ^[3][2]

These traditional formulations typically employ dosages of 5-15 g dried material daily, correlating strongly with modern extract yields (20-30% w/w) and LC50 values from cytotoxicity screening. ^[3]

PHYTOCHEMISTRY

Systematic solvent extractions (petroleum ether to ethanol) followed by chromatographic separations (TLC, HPLC, GC-MS) unveil a metabolomic repertoire dominated by polar secondary metabolites. Total phenolic content reaches 85 mg GAE/g in leaves, with flavonoid yields at 42 mg QE/g. Seeds uniquely harbor cardenolides, while leaves predominate in lipophilic fatty acids. ^{[6] [8][12]}

GC-MS chromatograms confirm palmitic acid dominance (RT 17.45 min, 34.69% relative peak area), followed by linolenic acid methyl ester (RT 20.12 min, 26.72%), validating leaf extracts as superior antioxidant sources compared to seed counterparts. ^[6]

Pharmacological Activities

Standardized 70% ethanolic extracts administered orally (200, 400, 500 mg/kg body weight in 0.5% Tween-80 vehicle) demonstrate robust, dose-dependent bioactivity across standardized rodent models, corroborated by histopathological validations and biomarker analyses.^[10]

Therapeutic indices remain favorable (TI > 4.0 across activities), positioning C. trilocularis extracts competitively against synthetic standards ^[10]

PHARMACOLOGICAL ACTIVITY COMPARISON BAR GRAPH

Figure 2: Comparative Efficacy of C. trilocularis Ethanolic Extract (500 mg/kg) Across Therapeutic Activities [3]

Caption: Bar graph comparing dose-standardized (500 mg/kg, p.o.) efficacy across validated rodent models. Values represent mean ± SEM (n=6-8/group). *p<0.01 vs control (ANOVA/Dunnett). Data compiled from primary studies

Mechanism of Action (MoA)

Gastroprotective Mechanisms: Flavonoid-tannin complexes competitively inhibit parietal cell H+/K+-ATPase (proton pump) with 45.2% reduction at IC50 23.4 μg/mL, complemented by prostaglandin E2 (PGE2)-mediated mucin glycoprotein upregulation (2.8-fold increase in adherent mucus layer). Nitric oxide (NO) pathway modulation via constitutive NOS activation prevents lipid peroxidation (MDA ↓61%), while antioxidant enzyme restoration (SOD ↑34%, CAT ↑29%, GPx ↑42%) neutralizes reactive oxygen species generated during NSAID injury. ^[16][10][11]

Anti-diabetic Mechanisms: Triterpenoids (ursolic/corosoic acids) act as partial PPAR-γ agonists (EC50 12.8 μM), facilitating GLUT4 translocation to plasma membranes and enhancing IRS-1/PI3K/Akt signaling (p-Akt ↑2.6-fold). Competitive α-amylase (IC50 22.5 μg/mL) and α-glucosidase (IC50 18.7 μg/mL) inhibition retards carbohydrate hydrolysis, while improved β-cell regeneration (insulin +28%) and glycogenesis contribute to sustained euglycemia. ^[16]

Antioxidant Mechanisms: Polyphenolics employ hydrogen atom transfer (HAT) and single electron transfer (SET) pathways; quercetin rutinoside stabilizes DPPH- radicals (kinetics k2 = 1.24 × 10? M?¹s?¹) via B-ring hydroxylation. Endogenous defense augmentation includes Nrf2-ARE pathway activation, boosting SOD (↑32%), catalase (↑28%), glutathione peroxidase (↑45%), and GSH:GSSG ratio restoration (3.8-fold).^[8][6]

Anti-inflammatory Mechanisms: Ursolic acid binds IKK-β allosteric site (IC50 15.2 μg/mL), blocking NF-κB p65 nuclear translocation and suppressing pro-inflammatory cascades (TNF-α ↓58%, IL-6 ↓62%, IL-1β ↓49%). Selective COX-2 inhibition (7.3-fold preference over COX-1) reduces PGE2 without gastric risk, complemented by 5-LOX blockade preventing leukotriene-mediated edema. ^[14][3]

Analgesic Mechanisms: Dual central (μ-opioid receptor agonism, naloxone-reversible) and peripheral (prostaglandin synthesis inhibition) pathways evident from hot plate latency increases (180% at 90 min) and writhing reductions (60%). Serotonergic/dopaminergic modulation contributes to tail flick responses. ^[16]
Toxicology & Safety Profile

Acute Toxicity: OECD Guideline 423 assays establish oral LD50 >2000 mg/kg (practically non-toxic, Category 5), with no mortality, behavioral alterations, or gross pathology at 2000 mg/kg across three dose escalation phases.^[3][10]

Sub-chronic Toxicity: OECD 408 (90-day repeated dose) at 100, 300, 1000 mg/kg reveals no hepato-renal impairment: ALT 42±3 U/L, AST 78±5 U/L, creatinine 0.8±0.1 mg/dL, BUN 18±2 mg/dL (all within normal ranges). Histopathological scores (liver, kidney, heart) remain Grade 0 (normal). Hematological parameters stable (RBC 8.2±0.4 × 10?/μL, WBC 6.8±0.6 × 10³/μL).^[10]

Genotoxicity: Ames test (Salmonella strains TA98, TA100) negative up to 5000 μg/plate; Comet assay shows <5% tail moment indicating no DNA damage.^[3]

Special Considerations: Seed cardenolides (0.2-0.5% w/w) pose digitalis-like arrhythmia risk at supratherapeutic doses (>2 g/kg extract equivalent); ECG monitoring recommended for cardiac patients. Leaves hold GRAS status (≤10 g fresh weight/day vegetable equivalent). Teratogenicity untested—contraindicated in pregnancy (traditional uterine stimulant reports). ^[13][7]

Comparison Table